British Journal of Medical & Surgical Urology
Volume 2, Issue 4 , Pages 138-146 , July 2009

The natural history of non-muscle-invasive transitional cell carcinoma of the bladder

  • A.J. Colquhoun

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Urology, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, United Kingdom. Tel.: +44 7703324776; fax: +44 1162584617.
    • ,
  • R.C. Kockelbergh

Received 20 April 2009 ,Accepted 23 April 2009.

References 

  1. CancerStats monograph. UK: Cancer Research; 2004;
  2. Avritscher EB, Cooksley CD, Grossman HB, et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology. 2006;68:549–553
  3. Sangar VK, Ragavan N, Matanhelia SS, Watson MW, Blades RA. The economic consequences of prostate and bladder cancer in the UK. BJU Int. 2005;95:59–63
  4. Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care. 1995;33:828–841
  5. Heney NM, Nocks BN, Daly JJ, et al. Ta and T1 bladder cancer: location, recurrence and progression. Brit J Urol. 1982;54:152–157
  6. Heney NM, Ahmed S, Flanaghan MJ, et al. Superficial bladder cancer: progression and recurrence. J Urol. 1983;130:1083–1086
  7. Lutzeyer W, Rübben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol. 1982;127:250–252
  8. England HR, Paris AMI, Blandy JP. The correlation of T1 bladder tumour history with prognosis and follow-up requirements. Brit J Urol. 1981;53:593–597
  9. Fitzpatrick JM, West AB, Butler MR, Lane V, O’Flynn JD. Superficial bladder tumours (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol. 1986;135:920–922
  10. Dalesio O, Schulmann CC, Sylvester R, et al. Prognostic factors in superficial bladder tumors. A study of the EORTC: genitourinary tract cancer cooperative group. J Urol. 1983;129:730–733
  11. Parmar MKB, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council subgroup on superficial bladder cancer (Urological Cancer Working Party). J Urol. 1989;142:284–288
  12. Reading J, Hall RR, Parmar MKB. The application of a prognostic factor analysis for Ta T1 bladder cancer in routine urological practice. Brit J Urol. 1995;75:604–607
  13. Kurth KH, Denis L, Bouffioux C, et al. Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer. 1994;31:1840–1846
  14. Prout G, Barton BA, Griffin PP, Froedell GH for the National Bladder Cancer Group. Treated history of non-invasive grade 1 transitional cell carcinoma. J Urol. 1992;148:1413–1419
  15. Mulders PFA, Hoekstra WJ, Heybroek RPM, et al. Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients. Eur J Cancer. 1994;30:914–917
  16. Holmäng S, Hedelin H, Anderström C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol. 1995;153:1823–1827
  17. Haukass S, Dæhlin L, Maartmann-Moe H, Ulvik NM. The long-term outcome in patients with superficial transitional cell carcinoma of the bladder: a single-institutional experience. BJU Int. 1999;83:957–963
  18. Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicnete-Rodríguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol. 2000;163:73–78
  19. Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41:523–531
  20. Althausen AF, Prout G, Daly J. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol. 1976;116:575–580
  21. Anderström C, Johansson S, Nilsson S. The significance of lamina propria invasion on the prognosis of patients with bladder tumours. J Urol. 1976;124:23–26
  22. Zieger K, Wolf H, Olsen PR, Højgaard K. Long-term survival of patients with bladder tumours: the significance of risk factors. Brit J Urol. 1998;82:667–672
  23. Wallace DMA, Bryan RT, Dunn JA, Begum G, Bathers S. Delay and survival in bladder cancer. BJU Int. 2002;89:868–878
  24. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466–475
  25. Mariappan P, Smith G. A surveillance schedule for G1pTa bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. J Urol. 2005;173:1108–1111

PII: S1875-9742(09)00070-6

doi: 10.1016/j.bjmsu.2009.04.005

British Journal of Medical & Surgical Urology
Volume 2, Issue 4 , Pages 138-146 , July 2009

Article Tools